These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4542187)

  • 1. Effect of single large doses of oral calcium on serum calcium levels in the young and the elderly.
    Epstein S; Van Mieghem W; Sagel J; Jackson WP
    Metabolism; 1973 Sep; 22(9):1163-73. PubMed ID: 4542187
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hypercalcemia after transition from calcium carbonate to calcium citrate in an elderly woman treated with ergocalciferol 50,000 IU per day.
    Drinka PJ; Moore J; Boushon MC
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):70-4. PubMed ID: 16730623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium stimulation of gastrin and gastric acid secretion: effect of small doses of calcium carbonate.
    Behar J; Hitchings M; Smyth RD
    Gut; 1977 Jun; 18(6):442-8. PubMed ID: 873325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis.
    Ginsburg DS; Kaplan EL; Katz AI
    Lancet; 1973 Jun; 1(7815):1271-4. PubMed ID: 4126071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Change in the serum concentration of phosphorus calcium and the metastatic calcification of certain tissues in rats administered varying doses of vitamin D2].
    Spirichev VB; Barkova LV
    Vopr Med Khim; 1974; 20(2):207-15. PubMed ID: 4548776
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercalcemia in patients with peptic ulceration receiving large doses of calcium carbonate.
    Stiel JN; Mitchell CA; Radcliff FJ; Piper DW
    Gastroenterology; 1967 Dec; 53(6):900-4. PubMed ID: 6065001
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man.
    Levant JA; Walsh JH; Isenberg JI
    N Engl J Med; 1973 Sep; 289(11):555-8. PubMed ID: 4723104
    [No Abstract]   [Full Text] [Related]  

  • 8. The hypolipidemic effect of calcium-containing compounds and vitamin D 2 in the rat.
    Fleischman AI; Bierenbaum ML; Lenz PH
    Lipids; 1972 Apr; 7(4):263-6. PubMed ID: 4537742
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein and fat utilization by humans as affected by calcium phosphate, calcium carbonate, and manganese gluconate supplements.
    Potter SM; Kies CV; Rojhani A
    Nutrition; 1990; 6(4):309-12. PubMed ID: 2134547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium carbonate treatment of uremic acidosis.
    Berlyne GM
    Isr J Med Sci; 1971 Nov; 7(11):1235-9. PubMed ID: 5159605
    [No Abstract]   [Full Text] [Related]  

  • 11. The calciferol requirements of patients with surgical hypoparathyroidism.
    Ireland AW; Clubb JS; Neale FC; Posen S; Reeve TS
    Ann Intern Med; 1968 Jul; 69(1):81-9. PubMed ID: 5301642
    [No Abstract]   [Full Text] [Related]  

  • 12. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged effect of glucagon on gastric secretion].
    Paul F; Deyhle P
    Klin Wochenschr; 1971 Nov; 49(22):1229-31. PubMed ID: 5132327
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of dihydrotachysterol and calciferol.
    Kaye M; Just G; Wilson M
    Can J Physiol Pharmacol; 1971 Oct; 49(10):857-61. PubMed ID: 5316524
    [No Abstract]   [Full Text] [Related]  

  • 15. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the embryotropic effects of various calcium compounds after peroral administration].
    Kuzanova IZ; Rakhmanin IuA
    Gig Sanit; 1990 Aug; (8):25-7. PubMed ID: 2283060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hypoparathyroidism. Hazards from vitamin D therapy.
    Fåhraeus B; Andersson L; Bergdahl L; Westling P
    Acta Chir Scand; 1973; 139(5):437-41. PubMed ID: 4542958
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for thyrocalcitonin in man.
    Williams GA; Hargis GK; Galloway WB; Henderson WJ
    Proc Soc Exp Biol Med; 1966; 122(4):1273-6. PubMed ID: 5918151
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
    Hutchison AJ; Freemont AJ; Boulton HF; Gokal R
    Nephrol Dial Transplant; 1992; 7(12):1219-25. PubMed ID: 1337163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.